Invitation to make submissions on application for facility licence under the Australian Radiation Protection and Nuclear Safety Act 1998

Overview

The Australian Radiation Protection and Nuclear Safety Act 1998 was enacted to establish a regulatory framework for the protection of people and the environment from the harmful effects of ionising radiation and for the safe use of nuclear technology. The Act addresses the problem of ensuring that facilities handling radioactive materials, such as the proposed molybdenum-99 production facility by ANSTO Nuclear Medicine Pty Ltd at Lucas Heights, are operated under stringent safety and regulatory standards. The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), acting under the authority of the Commonwealth Parliament, administers this Act. The policy objective is to maintain a high standard of protection for people and the environment by ensuring that nuclear and radiation activities are conducted safely and responsibly. ARPANSA's invitation for public submissions on the licence application reflects its commitment to transparency and public participation in the regulatory decision-making process.

Scope and Application

The Australian Radiation Protection and Nuclear Safety Act 1998 applies to entities and individuals seeking to operate nuclear installations, specifically in this case, ANSTO Nuclear Medicine Pty Ltd's application to produce molybdenum-99 at the Lucas Heights Science and Technology Centre in New South Wales. This Act is a Commonwealth legislation, establishing the framework for the regulation of radiation protection and nuclear safety across Australia. The scope of the Act extends to any person or entity involved in activities that involve ionising radiation, nuclear substances, or nuclear activities, ensuring these are conducted in a manner that protects public health and safety, and the environment. The Act's application is overseen by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), which is mandated to assess and grant licences for such activities, as well as to enforce compliance with radiation protection and nuclear safety standards. The public, including stakeholders directly affected by the proposed nuclear facility, is invited to submit comments on the licence application, ensuring transparency and community engagement in the decision-making process. Submissions to the CEO of ARPANSA must be made by 5 June 2017, with the understanding that these submissions may be made public, fostering an open and accountable regulatory environment.

Key Provisions

The Australian Radiation Protection and Nuclear Safety Act 1998, in particular section 32, provides the framework under which the Chief Executive Officer (CEO) of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) assesses applications for facility licences. In this case, ARPANSA is considering an application by ANSTO Nuclear Medicine Pty Ltd for a licence to operate a nuclear installation for the production of molybdenum-99 at Lucas Heights Science and Technology Centre in New South Wales. The CEO is required to review this application and make a decision on whether to grant the licence. Regulation 40 of the Australian Radiation Protection and Nuclear Safety Regulations 1999 mandates that ARPANSA invites public submissions on such applications to ensure transparency and inclusiveness in the decision-making process. The obligations imposed on the parties by this legislation are primarily centred around ensuring the safe and responsible operation of the nuclear facility. ANSTO Nuclear Medicine Pty Ltd must provide comprehensive information about their proposed operations, including safety measures, emergency response plans, and environmental impact assessments. ARPANSA, on the other hand, must carefully evaluate the application, consider public submissions, and make an informed decision based on the information provided and the regulatory requirements. Furthermore, the public has the right to submit their views and concerns, which ARPANSA must consider before making a final decision. Breaching the provisions of the Australian Radiation Protection and Nuclear Safety Act 1998 or the associated regulations can lead to serious consequences. ARPANSA has the authority to impose penalties for non-compliance with the Act. Offences under the Act can result in substantial fines, with the maximum penalty varying depending on the severity of the breach. Additionally, criminal charges may be brought against individuals or entities that violate the Act, leading to imprisonment. For instance, knowingly providing false or misleading information in a licence application can result in fines of up to $1.1 million for individuals and $5.5 million for corporations, along with potential imprisonment terms. It is crucial for all parties involved to adhere to the legislative requirements to avoid these severe consequences.